» Articles » PMID: 35440077

ROR Activation by Nobiletin Enhances Antitumor Efficacy Via Suppression of IκB/NF-κB Signaling in Triple-negative Breast Cancer

Abstract

Triple-negative breast cancer (TNBC) is a heterogeneous disease characterized by poor response to standard therapies and therefore unfavorable clinical outcomes. Better understanding of TNBC and new therapeutic strategies are urgently needed. ROR nuclear receptors are multifunctional transcription factors with important roles in circadian pathways and other processes including immunity and tumorigenesis. Nobiletin (NOB) is a natural compound known to display anticancer effects, and our previous studies showed that NOB activates RORs to enhance circadian rhythms and promote physiological fitness in mice. Here, we identified several TNBC cell lines being sensitive to NOB, by itself or in combination. Cell and xenograft experiments showed that NOB significantly inhibited TNBC cell proliferation and motility in vitro and in vivo. ROR loss- and gain-of-function studies showed concordant effects of the NOB-ROR axis on MDA-MB-231 cell growth. Mechanistically, we found that NOB activates ROR binding to the ROR response elements (RRE) of the IκBα promoter, and NOB strongly inhibited p65 nuclear translocation. Consistent with transcriptomic analysis indicating cancer and NF-κB signaling as major pathways altered by NOB, p65-inducible expression abolished NOB effects, illustrating a requisite role of NF-κB suppression mediating the anti-TNBC effect of NOB. Finally, in vivo mouse xenograft studies showed that NOB enhanced the antitumor efficacy in mammary fat pad implanted TNBC, as a single agent or in combination with the chemotherapy agent Docetaxel. Together, our study highlights an anti-TNBC mechanism of ROR-NOB via suppression of NF-κB signaling, suggesting novel preventive and chemotherapeutic strategies against this devastating disease.

Citing Articles

Long Intergenic Non-Coding RNAs and in Breast Cancer Pathogenesis: Neighboring Companions or Nemeses?.

Fadebi O, Miya T, Khanyile R, Dlamini Z, Marima R Noncoding RNA. 2025; 11(1).

PMID: 39997609 PMC: 11857994. DOI: 10.3390/ncrna11010009.


Mechanistic Insights into the Anticancer Potential of Methoxyflavones Analogs: A Review.

Aidiel M, Abdul Mutalib M, Ramasamy R, Nik Ramli N, Tang S, Adam S Molecules. 2025; 30(2).

PMID: 39860214 PMC: 11768088. DOI: 10.3390/molecules30020346.


An updated review summarizing the anticancer potential of flavonoids via targeting NF-kB pathway.

Pandey P, Lakhanpal S, Mahmood D, Kang H, Kim B, Kang S Front Pharmacol. 2025; 15():1513422.

PMID: 39834817 PMC: 11743680. DOI: 10.3389/fphar.2024.1513422.


Nobiletin reduces 5-FU-induced lung injury with antioxidative, anti-inflammatory and anti-apoptotic activities.

Atila Uslu G, Uslu H, Coban T, Ozkaraca M, Mendil A, Aygormez S Naunyn Schmiedebergs Arch Pharmacol. 2025; .

PMID: 39820543 DOI: 10.1007/s00210-024-03773-6.


The Role of Retinoic-Acid-Related Orphan Receptor (RORs) in Cellular Homeostasis.

Nematisouldaragh D, Kirshenbaum E, Uzonna M, Kirshenbaum L, Rabinovich-Nikitin I Int J Mol Sci. 2024; 25(21).

PMID: 39518891 PMC: 11545807. DOI: 10.3390/ijms252111340.


References
1.
Hong H, Maury E, Ramsey K, Perelis M, Marcheva B, Omura C . Requirement for NF-κB in maintenance of molecular and behavioral circadian rhythms in mice. Genes Dev. 2018; 32(21-22):1367-1379. PMC: 6217733. DOI: 10.1101/gad.319228.118. View

2.
Kim H, Lee J, Lee G, Bhin J, Oh S, Kim K . DNA damage-induced RORα is crucial for p53 stabilization and increased apoptosis. Mol Cell. 2011; 44(5):797-810. DOI: 10.1016/j.molcel.2011.09.023. View

3.
Petrenko V, Gandasi N, Sage D, Tengholm A, Barg S, Dibner C . In pancreatic islets from type 2 diabetes patients, the dampened circadian oscillators lead to reduced insulin and glucagon exocytosis. Proc Natl Acad Sci U S A. 2020; 117(5):2484-2495. PMC: 7007532. DOI: 10.1073/pnas.1916539117. View

4.
Liubomirski Y, Lerrer S, Meshel T, Rubinstein-Achiasaf L, Morein D, Wiemann S . Tumor-Stroma-Inflammation Networks Promote Pro-metastatic Chemokines and Aggressiveness Characteristics in Triple-Negative Breast Cancer. Front Immunol. 2019; 10:757. PMC: 6473166. DOI: 10.3389/fimmu.2019.00757. View

5.
Spengler M, Kuropatwinski K, Comas M, Gasparian A, Fedtsova N, Gleiberman A . Core circadian protein CLOCK is a positive regulator of NF-κB-mediated transcription. Proc Natl Acad Sci U S A. 2012; 109(37):E2457-65. PMC: 3443185. DOI: 10.1073/pnas.1206274109. View